Header

UZH-Logo

Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 12.

Derungs, R; Camici, G G; Spescha, R D; Welt, T; Tackenberg, C; Späni, C; Wirth, F; Grimm, A; Eckert, A; Nitsch, R M; Kulic, L (2017). Genetic ablation of the p66(Shc) adaptor protein reverses cognitive deficits and improves mitochondrial function in an APP transgenic mouse model of Alzheimer's disease. Molecular Psychiatry, 22(4):605-614.

Santuccione, A C; Merlini, M; Shetty, A; Tackenberg, C; Bali, J; Ferretti, M T; McAfoose, J; Kulic, L; Bernreuther, C; Welt, T; Grimm, J; Glatzel, M; Rajendran, L; Hock, C; Nitsch, R M (2013). Active vaccination with ankyrin G reduces β-amyloid pathology in APP transgenic mice. Molecular Psychiatry, 18(3):358-368.

Kulic, L; McAfoose, J; Welt, T; Tackenberg, C; Späni, C; Wirth, F; Finder, V; Konietzko, U; Giese, M; Eckert, A; Noriaki, K; Shimizu, T; Murakami, K; Irie, K; Rasool, S; Glabe, C; Hock, C; Nitsch, R M (2012). Early accumulation of intracellular fibrillar oligomers and late congophilic amyloid angiopathy in mice expressing the Osaka intra-Aβ APP mutation. Translational Psychiatry, 2:e183.

Erhardt, A; Müller, M B; Rödel, A; Welt, T; Ohl, F; Holsboer, F; Keck, M E (2009). Consequences of chronic social stress on behaviour and vasopressin gene expression in the PVN of DBA/2OlaHsd mice--influence of treatment with the CRHR1-antagonist R121919/NBI 30775. Journal of Psychopharmacology, 23(1):31-39.

Toschi, N; Welt, T; Guerrisi, M; Keck, M E (2009). Transcranial magnetic stimulation in heterogeneous brain tissue: clinical impact on focality, reproducibility and true sham stimulation. Journal of Psychiatric Research, 43(3):255-264.

Toschi, N; Welt, T; Guerrisi, M; Keck, M E (2008). A reconstruction of the conductive phenomena elicited by transcranial magnetic stimulation in heterogeneous brain tissue. Physica Medica, 24(2):80-86.

Unschuld, P G; Ising, M; Erhardt, A; Lucae, S; Kloiber, S; Kohli, M; Salyakina, D; Welt, T; Kern, N; Lieb, R; Uhr, M; Binder, E B; Müller-Myhsok, B; Holsboer, F; Keck, M E (2007). Polymorphisms in the serotonin receptor gene HTR2A are associated with quantitative traits in panic disorder. American Journal of Medical Genetics. Part B, 144B(4):424-429.

Kallweit, U; Harzheim, M; Marklein, G; Welt, T; Pöhlau, D (2007). Successful treatment of methicillin-resistant Staphylococcus aureus meningitis using linezolid without removal of intrathecal infusion pump. Journal of Neurosurgery, 107(3):651-653.

Welt, T; Engelmann, M; Renner, U; Erhardt, A; Müller, M B; Landgraf, R; Holsboer, F; Keck, M E (2006). Temazepam triggers the release of vasopressin into the rat hypothalamic paraventricular nucleus: novel insight into benzodiazepine action on hypothalamic-pituitary-adrenocortical system activity during stress. Neuropsychopharmacology, 31(12):2573-2579.

Keck, M E; Sartori, S B; Welt, T; Müller, M B; Ohl, F; Holsboer, F; Landgraf, R; Singewald, N (2005). Differences in serotonergic neurotransmission between rats displaying high or low anxiety/depression-like behaviour: effects of chronic paroxetine treatment. Journal of Neurochemistry, 92(5):1170-1179.

Keck, M E; Welt, T; Müller, M B; Uhr, M; Ohl, F; Wigger, A; Toschi, N; Holsboer, F; Landgraf, R (2003). Reduction of hypothalamic vasopressinergic hyperdrive contributes to clinically relevant behavioral and neuroendocrine effects of chronic paroxetine treatment in a psychopathological rat model. Neuropsychopharmacology, 28(2):235-243.

Keck, M E; Welt, T; Müller, M B; Landgraf, R; Holsboer, F (2003). The high-affinity non-peptide CRH1 receptor antagonist R121919 attenuates stress-induced alterations in plasma oxytocin, prolactin, and testosterone secretion in rats. Pharmacopsychiatry, 36(1):27-31.

This list was generated on Mon Sep 25 05:24:50 2017 CEST.